uic-94003 has been researched along with grl 98065 in 3 studies
Studies (uic-94003) | Trials (uic-94003) | Recent Studies (post-2010) (uic-94003) | Studies (grl 98065) | Trials (grl 98065) | Recent Studies (post-2010) (grl 98065) |
---|---|---|---|---|---|
18 | 0 | 4 | 5 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azijn, H; de Bethune, MP; de Kock, HA; De Meyer, S; Jonckers, TH; King, NM; Pauwels, R; Peeters, A; Pille, GM; Prabu-Jeyabalan, M; Schiffer, CA; Surleraux, DL; Tahri, A; Verschueren, WG; Wigerinck, PB | 1 |
Amano, M; Baldridge, A; Das, D; Davis, DA; Ghosh, AK; Koh, Y; Leschenko, S; Li, J; Matsumi, S; Mitsuya, H; Shioda, T; Yarchoan, R | 1 |
Ghosh, AK | 1 |
1 review(s) available for uic-94003 and grl 98065
Article | Year |
---|---|
Harnessing nature's insight: design of aspartyl protease inhibitors from treatment of drug-resistant HIV to Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Animals; Antiviral Agents; Aspartic Acid Endopeptidases; Biological Products; Darunavir; Drug Design; Drug Discovery; Drug Resistance, Viral; Enzyme Inhibitors; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Molecular Mimicry; Molecular Structure; Peptides; Structure-Activity Relationship; Sulfonamides | 2009 |
2 other study(ies) available for uic-94003 and grl 98065
Article | Year |
---|---|
Discovery and selection of TMC114, a next generation HIV-1 protease inhibitor.
Topics: Administration, Oral; Animals; Biological Availability; Cell Line; Crystallography, X-Ray; Darunavir; Dogs; Drug Resistance, Multiple, Viral; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; In Vitro Techniques; Microsomes, Liver; Models, Molecular; Molecular Conformation; Mutation; Rats; Stereoisomerism; Structure-Activity Relationship; Sulfonamides; Thermodynamics | 2005 |
Potent inhibition of HIV-1 replication by novel non-peptidyl small molecule inhibitors of protease dimerization.
Topics: Animals; CCR5 Receptor Antagonists; CD4 Antigens; Chlorocebus aethiops; COS Cells; Darunavir; Dimerization; Dose-Response Relationship, Drug; Enzyme Activation; Fluorescence Resonance Energy Transfer; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Protein Processing, Post-Translational; Pyridines; Pyrones; Receptors, CCR5; Sulfonamides; Virus Replication | 2007 |